Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 2
2009 2
2010 4
2011 5
2012 5
2013 4
2014 4
2017 1
2018 1
2020 1
2021 1
2022 2
2023 4
2024 5
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors.
Torrente E, Fodale V, Ciammaichella A, Ferrigno F, Ontoria JM, Ponzi S, Rossetti I, Sferrazza A, Amaudrut J, Missineo A, Esposito S, Palombo S, Nibbio M, Cerretani M, Bisbocci M, Cellucci A, di Marco A, Alli C, Pucci V, Toniatti C, Petrocchi A. Torrente E, et al. Among authors: sferrazza a. ACS Med Chem Lett. 2023 Jan 10;14(2):156-162. doi: 10.1021/acsmedchemlett.2c00454. eCollection 2023 Feb 9. ACS Med Chem Lett. 2023. PMID: 36793438 Free PMC article.
Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus.
Specchia ML, de Waure C, Gualano MR, Doria A, Turchetti G, Pippo L, Di Nardo F, Capizzi S, Cadeddu C, Kheiraoui F, Iaccarino L, Pierotti F, Palla I, Veneziano MA, Gliubizzi D, Sferrazza A, Nicolotti N, Porcasi R, La Torre G, Di Pietro ML, Ricciardi W. Specchia ML, et al. Among authors: sferrazza a. Biomed Res Int. 2014;2014:704207. doi: 10.1155/2014/704207. Epub 2014 Aug 17. Biomed Res Int. 2014. PMID: 25243173 Free PMC article.
Fertility and abortion: A population-based comparison between women with cancer and those in childbearing age.
Maraschini A, Corsi Decenti E, Donati S, Francisci S, Lopez T, Amodio R, Bianconi F, Bovo E, Bruni R, Castaing M, Cirilli C, De Vincenzo RP, Furgiuele G, Guarda L, Iacovacci S, Mangone L, Mazzucco W, Melcarne A, Merlo E, Mian M, Sampietro G, Scambia G, Scuderi T, Sferrazza A, Stracci F, Torrisi A, Trojano V, Vitale MF, Pierannunzio D. Maraschini A, et al. Among authors: sferrazza a. Tumori. 2025 Feb;111(1):71-78. doi: 10.1177/03008916241298810. Epub 2024 Dec 2. Tumori. 2025. PMID: 39620650 Free PMC article.
Intrafamilial transmission of hepatitis C virus in Italy: a systematic review.
de Waure C, Cefalo C, Chiaradia G, Sferrazza A, Miele L, Gasbarrini G, Ricciardi W, Grieco A, La Torre G. de Waure C, et al. Among authors: sferrazza a. J Epidemiol Community Health. 2010 Oct;64(10):843-8. doi: 10.1136/jech.2009.087965. Epub 2009 Aug 25. J Epidemiol Community Health. 2010. PMID: 19710041
The prevention of postmenopausal osteoporotic fractures: results of the Health Technology Assessment of a new antiosteoporotic drug.
de Waure C, Specchia ML, Cadeddu C, Capizzi S, Capri S, Di Pietro ML, Veneziano MA, Gualano MR, Kheiraoui F, La Torre G, Nicolotti N, Sferrazza A, Ricciardi W. de Waure C, et al. Among authors: sferrazza a. Biomed Res Int. 2014;2014:975927. doi: 10.1155/2014/975927. Epub 2014 Feb 4. Biomed Res Int. 2014. PMID: 24689066 Free PMC article.
Withdrawal notice to <Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]>
Iacovino ML, Celant S, Tomassini L, Arenare L, Caglio A, Canciello A, Salerno F, Olimpieri PP, Di Segni S, Sferrazza A, Piccirillo MC, Beretta GD, Pinto C, Blasi L, Cinieri S, Cavanna L, Di Maio M, Russo P, Perrone F. Iacovino ML, et al. Among authors: sferrazza a. Lancet Reg Health Eur. 2024 Sep 2;44:101012. doi: 10.1016/j.lanepe.2024.101012. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39444700 Free PMC article.
Novel azabicyclic series of potent SHP2 allosteric inhibitors.
Sferrazza A, Rossetti I, Fabbrini D, Torrente E, Relitti N, Ferrigno F, Fezzardi P, Iaccarino C, Bisbocci M, Cellucci A, Ventre D, Anzillotti L, Palombo S, Nibbio M, Alli C, Montalbetti C, Toniatti C, Petrocchi A. Sferrazza A, et al. Bioorg Med Chem Lett. 2025 Dec 15;129:130383. doi: 10.1016/j.bmcl.2025.130383. Epub 2025 Aug 19. Bioorg Med Chem Lett. 2025. PMID: 40840719
42 results